In Acular Patent Feud, Apotex Suffers Blow
In the latest setback for Canadian generic drug maker Apotex Inc. in its battle to market a generic version of leading itchy eye treatment Acular, a federal court has ruled that...To view the full article, register now.
Already a subscriber? Click here to view full article